Page 717 - 16Neonatal Jaundice_compressed
P. 717

Abbreviations, glossary and references






              References


              1.    Rennie JM, Seghal A,  De A  et  al.  Range of  UK practice regarding  thresholds  for phototherapy and  exchange transfusion  in
                  neonatal hyperbilirubinaemia. Archives of Disease in Childhood Fetal and Neonatal Edition 2009; 94: F323-F327.
              2.    NHS Executive. Clinical Guidelines: Using Clinical Guidelines to Improve Patient Care Within the NHS. London: HMSO; 1996.
              3.    Oxman AD, Sackett DL, and Guyatt GH. Users' guide to the medical literature. I. How to get started. JAMA: the journal of the
                  American Medical Association 1993; 270:(17)2093-5.
              4.    Guyatt GH, Sackett  DL, and Cook DJ. Users' guides  to the  medical  literature.  II. How  to  use an article about therapy or
                  prevention. A. Are the results of the study valid? Evidence-Based Medicine Working Group. JAMA: the journal of the American
                  Medical Association 1993; 270:(21)2598-601.
              5.    Guyatt GH, Sackett  DL, and Cook DJ. Users' guides  to the  medical  literature.  II. How  to  use an article about therapy or
                  prevention. B. What were the results and will they help me in caring for my patients? Evidence-Based Medicine Working Group.
                  JAMA: the journal of the American Medical Association 1994; 271:(1)59-63.
              6.    Jaeschke R, Guyatt G, and Sackett DL. Users' guides to the medical literature. III. How to use an article about a diagnostic test. A.
                  Are the results of  the study valid? Evidence-Based Medicine  Working Group.  JAMA: the  journal of  the American Medical
                  Association 1994; 271:(5)389-91.
              7.    Jaeschke R, Guyatt GH, and Sackett DL. Users' guides to the medical literature. III. How to use an article about a diagnostic test.
                  B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA: the
                  journal of the American Medical Association 1994; 271:(9)703-7.
              8.    National Institute for Health and Clinical Excellence. The guidelines manual 2006. London: NICE; 2006.
              9.    Newman TB, Xiong B, Gonzales VM et al. Prediction and prevention of extreme neonatal hyperbilirubinemia in a mature health
                  maintenance organization. Archives of Pediatrics and Adolescent Medicine 2000; 154:(11)1140-7.
              10.   Newman  TB,  Liljestrand  P,  and  Escobar  GJ.  Jaundice  noted  in  the  first  24  hours  after  birth  in  a  managed  care  organization.
                  Archives of Pediatrics and Adolescent Medicine 2002; 156:(12)1244-50.
              11.   Kuzniewicz MW, Escobar GJ, Wi S et al. Risk factors for severe hyperbilirubinemia among infants with borderline bilirubin levels:
                  a nested case-control study. Journal of Pediatrics 2008; 153:(2)234-40.
              12.   Keren R, Bhutani VK, Luan X  et al.  Identifying newborns at risk  of significant hyperbilirubinaemia: a comparison of  two
                  recommended approaches. Archives of Disease in Childhood 2005; 90:(4)415-21.
              13.   Seidman DS, Ergaz Z, Paz I et al. Predicting the risk of jaundice in full-term healthy newborns: a prospective population-based
                  study. Journal of Perinatology 1999; 19:(8 Pt 1)564-7.
              14.   Keren  R, Luan  X, Friedman  S  et  al.  A  comparison  of  alternative  risk-assessment strategies  for predicting  significant  neonatal
                  hyperbilirubinemia in term and near-term infants. Pediatrics 2008; 121:(1)e170-e179.
              15.   Gale  R,  Seidman  DS,  Dollberg  S  et  al.  Epidemiology  of  neonatal  jaundice  in  the  Jerusalem  population.  Journal  of  Pediatric
                  Gastroenterology and Nutrition 1990; 10:(1)82-6.
              16.   Khoury MJ, Calle EE, and Joesoef RM. Recurrence risk of neonatal hyperbilirubinemia in siblings. American Journal of Diseases of
                  Children 1988; 142:(10)1065-9.
              17.   Maisels  MJ,  DeRidder  J.M.,  and  Kring  EA.  Routine  transcutaneous  bilirubin  measurements  combined  with  clinical  risk factors
                  improve the prediction of subsequent hyperbilirubinemia. Journal of Perinatology 2009; 29:612-7.
              18.   Beal AC, Chou SC, Palmer RH et al. The changing face of race: risk factors for neonatal hyperbilirubinemia. Pediatrics 2006;
                  117:(5)1618-25.
              19.   American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant
                  35 or more weeks of gestation.[see comment][erratum appears in Pediatrics. 2004 Oct;114(4):1138]. Pediatrics 2004; 114:(1)297-
                  316.
              20.   Bhutani VK and Johnson L. Kernicterus in late preterm infants cared for as term healthy infants. Seminars in Perinatology 2006;
                  30:(2)89-97.
              21.   Turkel SB, Guttenberg ME, Moynes DR et al. Lack of identifiable risk factors for kernicterus. Pediatrics 1980; 66:(4)502-6.
              22.   Murki S, Kumar P, Majumdar S et al. Risk factors for kernicterus in term babies with non-hemolytic jaundice. Indian Pediatrics
                  2001; 38:(7)757-62.
              23.   Newman TB and Klebanoff MA. Neonatal hyperbilirubinemia and long-term outcome: another look at the Collaborative Perinatal
                  Project.[see comment]. Pediatrics 1993; 92:(5)651-7.
              24.   Oh W, Tyson JE, Fanaroff AA et al. Association between peak serum bilirubin and neurodevelopmental outcomes in extremely
                  low birth weight infants. Pediatrics 2003; 112:(4)773-9.
              25.   Boo NY, Oakes M, Lye MS et al. Risk factors associated with hearing loss in term neonates with hyperbilirubinaemia. Journal of
                  Tropical Pediatrics 1994; 40:(4)194-7.
              26.   Carbonell X, Botet F, Figueras J  et al.  Prediction of hyperbilirubinaemia in the healthy term newborn.  Acta Paediatrica  2001;
                  90:(2)166-70.
              27.   Agarwal R, Kaushal M, Aggarwal R et al. Early neonatal hyperbilirubinemia using first day serum bilirubin level. Indian Pediatrics
                  2002; 39:(8)724-30.
              28.   Alpay F, Sarici SU, Tosuncuk HD et al. The value of first-day bilirubin measurement in predicting the development of significant
                  hyperbilirubinemia in healthy term newborns. Pediatrics 2000; 106:(2)E16.
              29.   Knudsen A. Prediction of later hyperbilirubinaemia by measurement of skin colour on the first postnatal day and from cord blood
                  bilirubin. Danish Medical Bulletin 1992; 39:(2)193-6.
              30.   Knupfer M, Pulzer F, Gebauer C et al. Predictive value of umbilical cord blood bilirubin for postnatal hyperbilirubinaemia. Acta
                  Paediatrica 2005; 94:(5)581-7.
              31.   Taksande A, Vilhekar K, Jain M et al. Prediction of the development of neonatal hyperbilirubinemia by increased umbilical cord
                  blood bilirubin. Current Pediatric Research 2005; 9:(1-2)5-2.
              32.   Stevenson DK, Fanaroff AA, Maisels MJ et al. Prediction of hyperbilirubinemia in near-term and term infants. Pediatrics 2001;
                  108:(1)31-9.


                                                                                                        511
   712   713   714   715   716   717   718   719   720   721   722